Cargando…
Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer
Antibody-recruiting molecules (ARMs) are one of the most promising tools to redirect the immune response towards cancer cells. In this review, we aim to highlight the recent advances in the field. We will illustrate the advantages of different ARM approaches and emphasize the importance of a multiva...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190906/ https://www.ncbi.nlm.nih.gov/pubmed/34212148 http://dx.doi.org/10.1039/d1cb00007a |
_version_ | 1783705777409622016 |
---|---|
author | Achilli, Silvia Berthet, Nathalie Renaudet, Olivier |
author_facet | Achilli, Silvia Berthet, Nathalie Renaudet, Olivier |
author_sort | Achilli, Silvia |
collection | PubMed |
description | Antibody-recruiting molecules (ARMs) are one of the most promising tools to redirect the immune response towards cancer cells. In this review, we aim to highlight the recent advances in the field. We will illustrate the advantages of different ARM approaches and emphasize the importance of a multivalent presentation of the binding units. |
format | Online Article Text |
id | pubmed-8190906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | RSC |
record_format | MEDLINE/PubMed |
spelling | pubmed-81909062021-06-29 Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer Achilli, Silvia Berthet, Nathalie Renaudet, Olivier RSC Chem Biol Chemistry Antibody-recruiting molecules (ARMs) are one of the most promising tools to redirect the immune response towards cancer cells. In this review, we aim to highlight the recent advances in the field. We will illustrate the advantages of different ARM approaches and emphasize the importance of a multivalent presentation of the binding units. RSC 2021-03-04 /pmc/articles/PMC8190906/ /pubmed/34212148 http://dx.doi.org/10.1039/d1cb00007a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Achilli, Silvia Berthet, Nathalie Renaudet, Olivier Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer |
title | Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer |
title_full | Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer |
title_fullStr | Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer |
title_full_unstemmed | Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer |
title_short | Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer |
title_sort | antibody recruiting molecules (arms): synthetic immunotherapeutics to fight cancer |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190906/ https://www.ncbi.nlm.nih.gov/pubmed/34212148 http://dx.doi.org/10.1039/d1cb00007a |
work_keys_str_mv | AT achillisilvia antibodyrecruitingmoleculesarmssyntheticimmunotherapeuticstofightcancer AT berthetnathalie antibodyrecruitingmoleculesarmssyntheticimmunotherapeuticstofightcancer AT renaudetolivier antibodyrecruitingmoleculesarmssyntheticimmunotherapeuticstofightcancer |